Next Biomedical Co.,Ltd. (KOSDAQ:389650)
33,250
+950 (2.94%)
At close: Aug 24, 2026
Next Biomedical Revenue
Next Biomedical had revenue of 4.94B KRW in the quarter ending June 30, 2026, with 24.28% growth. This brings the company's revenue in the last twelve months to 17.79B, up 46.25% year-over-year. In the year 2025, Next Biomedical had annual revenue of 16.48B with 72.67% growth.
Revenue (ttm)
17.79B
Revenue Growth
+46.25%
P/S Ratio
15.03
Revenue / Employee
n/a
Employees
n/a
Market Cap
267.36B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.48B | 6.93B | 72.67% |
| Dec 31, 2024 | 9.54B | 4.66B | 95.46% |
| Dec 31, 2023 | 4.88B | 2.09B | 74.67% |
| Dec 31, 2022 | 2.80B | 527.74M | 23.28% |
| Dec 31, 2021 | 2.27B | 6.63M | 0.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRGEM | 106.74B |
| MEDIANA Co.,Ltd | 66.00B |
| JPI Healthcare | 47.97B |
| L&K Biomed | 39.53B |
| ASTERASYS Co.,Ltd | 38.72B |
| Hironic | 34.19B |
| SELVAS Healthcare | 30.19B |
| Remed | 27.05B |